Not Signed In - Tolterodine Extended-Release Does Not Impair Memory In Patients With Overactive Bladder
Fri, 01 Dec 2006 04:00 PM EST
... CHRISTCHURCH, NEW ZEALAND - Tolterodine tartrate extended-release or ER (Detrol LAR), 4 mg per day, does not affect recent memory in healthy older patients with overactive bladder, according to data reported today at the 36th Annual Meeting of the International Continence Society (ICS). [click link for full article] ...
Related Topics
- Overactive Bladder
- Memory
- Carbinoxamine and Pseudoephedrine Extended-Release Tablets
- Bladder
- Niacin Extended Release
- Lovastatin Extended Release
- What Your Female Patients Want to Know About Bladder Control
- Bladder Cancer
- Tolterodine
- Valproic Acid Delayed or Extended-Release or Sprinkle Capsule
- Infection (bladder)
- Metformin Extended-Release
- Pseudoephedrine Extended Release
- Bladder Diseases
- Memory Disorders
- Bupropion Extended-Release
- Chlorpromazine Extended-Release Capsules
- Bladder Control
- Quinidine Extended-Release
- Isradipine Extended-Release Tablets
email this page
print this page
bookmark this page
feedback on this page
